An Overview of the Orphan Medicines Market in Turkey Güvenç Koçkaya, MD, MsC, Albert I. Wertheimer, MBA, PhD, Pelin Kilic, MsC, Pelin Tanyeri, MD, İ. Mert Vural, MD, Akif Akbulat, MD, Guven Artiran, MD, Saim Kerman, MD Value in Health Regional Issues Volume 4, Pages 47-52 (September 2014) DOI: 10.1016/j.vhri.2014.06.009 Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 1 Overview of licensed product market access in Turkey [17]. MEEC, Medical and Economic Evaluation Commission; SGK, Sosyal Güvenlik Kurumu; TITCK, Türkiye İlaç ve Tıbbi Cihaz Kurumu. Value in Health Regional Issues 2014 4, 47-52DOI: (10.1016/j.vhri.2014.06.009) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 2 Changes in units and expenditures from 2008 to 2010. Value in Health Regional Issues 2014 4, 47-52DOI: (10.1016/j.vhri.2014.06.009) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions